Junli He - 25 Nov 2025 Form 4 Insider Report for Harvard Apparatus Regenerative Technology, Inc. (HRGN)

Reporting relationship: CEO, Director
Issuer ticker: HRGN
Reported as of: 25 Nov 2025
Net transaction value: +$5,100
SEC form: 4
Accepted by SEC: 01 Dec 2025, 12:54:12 UTC
Prior SEC filing: 01 Oct 2025
Next SEC filing: 11 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Joseph Damasio by power of attorney

Key filing fact

Junli He filed Form 4 for Harvard Apparatus Regenerative Technology, Inc. (HRGN) on 01 Dec 2025.

Key facts

This page summarizes Junli He's Form 4 filing for Harvard Apparatus Regenerative Technology, Inc. (HRGN).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 01 Dec 2025, 12:54.

Change

Previous filing in this sequence was filed on 01 Oct 2025.
Current net transaction value: +$5,100.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001728598 Primary reporting owner

He Junli

Relationship: CEO, Director
Address: C/O HREGEN, 84 OCTOBER HILL ROAD, SUITE 11, HOLLISTON
Signature: /s/ Joseph Damasio by power of attorney
Signature date: 01 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HRGN transaction

Common Stock

Purchase

Transaction value: $5,100
Shares: +3,000
Change %: +1.1%
Price: $1.70
Shares after: 280,575
Date: 25 Nov 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions from November 25, 2025 to November 26, 2025. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.